(Q34936648)

5 August 2017

1 reference

title

The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants (English)

1 reference

5 August 2017

1 reference

Herschel A Carpenter

1

1 reference

5 August 2017

Albert J Czaja

series ordinal

2

1 reference

5 August 2017

publication date

1 August 2002

1 reference

5 August 2017

published in

Clinics in liver disease

1 reference

5 August 2017

volume

6

1 reference

5 August 2017

issue

3

1 reference

5 August 2017

page(s)

685-705

1 reference

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Meeting report: International Autoimmune Hepatitis Group

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Autoimmune hepatitis. Evolving concepts and treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Diagnosis and therapy of autoimmune liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Drug therapy in the management of type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Natural history, clinical features, and treatment of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Autoimmune hepatitis and its variant syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Autoimmune hepatitis: the investigational and clinical challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Chronic active hepatitis: the challenge for a new nomenclature

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Frequency and nature of the variant syndromes of autoimmune liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

The variant forms of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Variant forms of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine A

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Autoimmune chronic active hepatitis responsive to immunosuppressive therapy evolving into a typical primary biliary cirrhosis syndrome: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Autoimmune cholangitis and primary biliary cirrhosis--an autoimmune enigma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

An atypical presentation for primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

A 28-year-old woman with a combined hepatitic/cholestatic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Autoimmune cholangitis within the spectrum of autoimmune liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Autoimmune cholangitis syndrome with a bias towards primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Chronic hepatitis with combined features of autoimmune chronic hepatitis and chronic hepatitis C: favorable response to prednisone and azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Histological findings in chronic hepatitis C with autoimmune features

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

The pathology of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Chronic hepatitis C and autoimmunity: good response to immunosuppressive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

The nature and prognosis of severe cryptogenic chronic active hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Understanding the pathogenesis of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Autoimmune hepatitis with incidental histologic features of bile duct injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Validation of scoring system for diagnosis of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Corticosteroid-treated chronic active hepatitis in remission: uncertain prognosis of chronic persistent hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Azathioprine for long-term maintenance of remission in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Chronic Hepatitis: To Treat or Not to Treat?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Severe chronic active liver disease. Prognostic significance of initial morphologic patterns

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Prognosis of histological cirrhosis in type 1 autoimmune hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Recent-onset autoimmune hepatitis. Biopsy findings and clinical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

'Acute' autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

The nature and prognostic implications of autoimmune hepatitis with an acute presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Anti-liver-kidney microsome antibody-positive autoimmune hepatitis presenting as fulminant liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Autoantibodies in liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Host- and disease-specific factors affecting steatosis in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Postinfantile giant-cell transformation in hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Syncytial giant-cell hepatitis--a specific disease entity?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

A novel histological lesion in glucocorticoid-responsive chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Immunologic features and HLA associations in chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900022-3

7 January 2021

10.1016/S1089-3261(02)00022-3

Identifiers

DOI

1 reference

5 August 2017

1 reference